Acies SAS

Acies SAS is a company in Lyon, France that has taken part in 3 EU-funded projects since 2008, receiving €90k in EU funding.

EU funding received€90k
EU projects3
As coordinator0
Running now0
First EU project2008
Latest project2009
CountryFrance
EU registration (PIC)998949554
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Acies SAS's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€90k · 3 projects

Projects

3 EU-funded projects, newest first. Each links to the official record.

  • PERSISTPartner

    Persisting Transgenesis

    FP7 (2007 to 2013) · 2009–2013 · Project on CORDIS ↗

    €20ktheir share
  • SPIDIAPartner

    Standardisation and improvement of generic pre-analytical tools and procedures for in vitro diagnostics

    FP7 (2007 to 2013) · 2008–2013 · Project on CORDIS ↗

    €17ktheir share
  • SYBILLAPartner

    Systems Biology of T-cell Activation in Health and Disease

    FP7 (2007 to 2013) · 2008–2013 · Project on CORDIS ↗

    €54ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • RNA
  • alzheimer
  • autoimmune diseases
  • cell signaling
  • gene therapy
  • multiple sclerosis
  • proteins
  • transition metals

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime